Evidence map›Paper›PMID 38178109›Full record

ArticleBMC health services research2024

Cost and availability of selected medicines after implementation of increased import verification fees.

Helen Byomire Ndagije, Diana Nakitto Kesi, Kalidi Rajab, Solomon Onen, Allan Serwanga, Leonard Manirakiza, Sheila Ampaire, Joseph Mutasaaga, Denis Mwesigwa, David Nahamya

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Helen Byomire NdagijeNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.
Diana Nakitto KesiNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda. dnakitto@nda.or.ug.
Kalidi RajabDepartment of Pharmacy, School of Health Sciences, College of Health Sciences, Makerere University, University Rd, 10218, Kampala, Uganda.
Solomon OnenNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.
Allan SerwangaNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.
Leonard ManirakizaUganda National Bureau of Standards, Plot 2-12 By pass Link Bweyogerere Industrial and Business Park, Kampala, Uganda.
Sheila AmpaireNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.
Joseph MutasaagaNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.
Denis MwesigwaNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.
David NahamyaNational Drug Authority, Plot 46-48 Lumumba Avenue, P.O.Box 23096, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUganda imports approximately 90% of its medicines, with about 60% being distributed by the private sector. To discourage importation and promote local production of 37 selected locally manufactured medicines, the Ugandan government through the Ministry of Health in 2017 increased the import verification fees from 2 to 12%. The increase in verification fees ultimately affects cost and availability of these medicines. This study aimed to assess the cost and availability of the selected essential medicines after the 12% increase in verification fees in Uganda.

methodsA cross sectional study among 328 wholesale and retail pharmacies and seven key informant interviews was conducted using a pretested data collection checklist and in-depth interview guide from February to September 2021 in Uganda. Data on the availability and prices of the medicines before (2017) and after (2020) the increase in verification fees was collected. Paired sample T-Test was used to test if there is a significant difference in prices before and after the 12% increase in verification fees.

resultsMean availability of imported medicines was higher (54.8%, CI: 49.3-60.4) than the locally produced medicines (37.1%, CI: 31.9-42.7) except for locally manufactured parenteral preparations (54.6.%, CI: 49.1-60.1). Availability of locally produced medicines was mainly low (45%) while the imported medicines were fairly high (74%). Most commonly available locally manufactured medicines were Surgical spirit (89.9%), ORS (86%), Dextrose 5% solution (74.4%), Paracetamol 500 mg Tablets (73.8%) and Sodium Chloride 0.9% solution (72.9%). Most commonly available imported medicines were; Omeprazole 20 mg (94.2%), Amoxicillin Trihydrate 125 mg/5 ml (92.4%), Ciprofloxacin 500 mg (91.4%), Paracetamol Suspension 120 mg/5 ml (91.5%) and Metronidazole 200 mg Tablets (88.1%). Increase in lowest-priced local and imported medicines was significant for 10 (23.8%) and 7 (15.9%) of the medicines respectively. The median prices of imported medicines were generally higher than locally produced medicines. The median unit prices of 12 (28.6%) locally produced medicines and 20 (47.6%) imported medicines were higher than the international median unit prices.

conclusionsThe overall availability of imported medicines was still higher than the local medicines. The median prices of local and imported medicines generally increased or remained the same after the introduction of import verification fees. There is a need for price controls and transparency in the private sector.

Indexed as

AcetaminophenDrugs, EssentialChecklistCross-Sectional StudiesHealth Services AccessibilityHumansPublic SectorAcetaminophenDrugs, EssentialAvailability of medicinesCost of medicinesImported productsImport verification feesLocal products

Identifiers

PMID38178109
PMCPMC10768383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.